Missed the presentation so if anyone could clarify the following points it would be much appreciated.
- we will be receiving the "headline results" for the phase II clinical trials, hopefully prior to the AGM in November.
- was the length of phase III discussed as the usual process with the FDA takes between 6-10 months of trials with large/mass groups of people and tested for efficiency against current drugs being used.
- was any company or organisation singled out during the presentation as an interested party or will that process start publicly after the results are released?
Thanks.
Missed the presentation so if anyone could clarify the following...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.38M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 10500 | 1 |
View Market Depth
| Last trade - 08.14am 28/06/2024 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable